Xuege Wu
YOU?
Author Swipe
View article: Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation
Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation Open
Background Netherton syndrome is a rare, life-threatening autosomal recessive genetic disorder with no effective treatment yet. Skin barrier dysfunction caused by SPINK5 gene mutations is a hallmark of the disease. Antigen penetration thro…